Ending Discrimination in COVID–19 Treatments Act

Bill: 117-s-3974
Sponsor: full_name: Sen. Cruz, Ted [R-TX]
Introduced: 2022-03-31
Policy area: Health
Subjects: Disability and health-based discrimination

Drug therapy

Immunology and vaccination

Infectious and parasitic diseases

State and local government operations
Latest action: action_date: 2022-03-31
text: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Summaries:
action_date: 2022-03-31
action_desc: Introduced in Senate
text: <p><strong>Ending Discrimination in COVID-19 Treatments Act</strong></p> <p>This bill prohibits consideration of certain factors, including vaccination status, in decisions about an individual's access to federally provided monoclonal antibody therapies to treat COVID-19.</p> <p>As a condition of receiving the therapies from the federal government, states must ensure that providers do not consider specified demographic characteristics, veteran status, or political ideology or speech when determining a patient's eligibility for such therapies.</p>

tv_txt: II 117th CONGRESS 2d Session S. 3974 IN THE SENATE OF THE UNITED STATES March 31, 2022 Mr. Cruz introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions A BILL To prohibit the consideration of patients' race, color, religion, sex, national origin, age, disability, vaccination status, veteran status, or political ideology or speech in determining eligibility for monoclonal antibody doses distributed by the Federal Government.

1. Short title This Act may be cited as the Ending Discrimination in COVID–19 Treatments Act . 2. Eligibility to receive monoclonal antibody treatment The Secretary of Health and Human Services shall require States, as a condition for receipt of monoclonal antibody doses from the Federal Government, to ensure that providers receiving distributions of such monoclonal antibody doses from such States do not take into consideration the race, color, religion, sex, national origin, age, disability, vaccination status, veteran status, or political ideology or speech of a patient in determining whether a patient is eligible to receive such treatment.